ACTGenomics is the first one to receive approval for laboratory-developed NGS tests and services (LDTS) in Taiwan

2020-05-28

ACTGenomics received approval for our laboratory-developed NGS tests and services (LDTS) as the first NGS laboratory numbered LDT0001, announced by Taiwan Food and Drug Administration recently. We are glad to introduce our LDTS panels in the markets : ACTOnco® +ACTDrug® +ACTFusion ACTMonitor®LungACTBRCA® / ACTBRCA® HRD .

Taiwan Food and Drug Administration Announcement of LDTs